
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 29 results:
[ Author
Filters: Author is Garcia Rodriguez, L. A. [Clear All Filters]
“A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs”, Br J Clin Pharmacol, vol. 48, pp. 847-52, 1999.
, “Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed”, Epidemiology, vol. 10, pp. 228-32, 1999.
, “Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study”, Epidemiology, vol. 11, pp. 376-81, 2000.
, “Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome”, Scand J Gastroenterol, vol. 35, pp. 306-11, 2000.
, “Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women”, Epidemiology, vol. 11, pp. 382-7, 2000.
, “Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs”, Epidemiology, vol. 12, pp. 570-6, 2001.
, “The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents”, Arthritis Res, vol. 3, pp. 98-101, 2001.
, “Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure”, Epidemiology, vol. 14, pp. 240-6, 2003.
, “Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer”, Cancer Epidemiol Biomarkers Prev, vol. 13, pp. 649-53, 2004.
, “Risk of breast cancer among users of aspirin and other anti-inflammatory drugs”, Br J Cancer, vol. 91, pp. 525-9, 2004.
, “Use of antibiotics and risk of breast cancer”, Am J Epidemiol, vol. 161, pp. 616-9, 2005.
, “Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease”, Gastroenterology, vol. 130, pp. 1588-94, 2006.
, “Relationship between gastroesophageal reflux disease and COPD in UK primary care”, Chest, vol. 134, pp. 1223-1230, 2008.
, “Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors”, Copd, vol. 6, pp. 369-79, 2009.
, “Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding”, Thromb Haemost, vol. 110, pp. 1014-24, 2013.
, “Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs”, Bmj, vol. 308, pp. 503-6, 1994.
, “Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs”, Lancet, vol. 343, pp. 769-72, 1994.
, “Ocular safety of antiulcer drugs”, Lancet, vol. 345, pp. 1059-60, 1995.
, “Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors”, Arch Intern Med, vol. 154, pp. 311-6, 1994.
, “A cohort study of the ocular safety of anti-ulcer drugs”, Br J Clin Pharmacol, vol. 42, pp. 213-6, 1996.
, “Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?”, Epidemiology, vol. 8, pp. 571-4, 1997.
, “A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom”, Pharmacotherapy, vol. 17, pp. 721-8, 1997.
, “Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid”, Arch Intern Med, vol. 156, pp. 1327-32, 1996.
, “Renal disease and acid-suppressing drugs”, Pharmacoepidemiol Drug Saf, vol. 6, pp. 247-51, 1997.
, “The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs”, Br J Clin Pharmacol, vol. 43, pp. 183-8, 1997.
, “Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs”, Arch Intern Med, vol. 158, pp. 33-9, 1998.
, “Use of the UK General Practice Research Database for pharmacoepidemiology”, Br J Clin Pharmacol, vol. 45, pp. 419-25, 1998.
, “Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents”, Epidemiology, vol. 9, pp. 452-6, 1998.
, “Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK”, BMJ Open, vol. 9, p. e031341, 2019.
,